Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations

Bordetella pertussis and Bordetella bronchiseptica belong to the genus Bordetella, which comprises 14 other species. B. pertussis is responsible for whooping cough in humans, a severe infection in children and less severe or chronic in adults. These infections are restricted to humans and currently increasing worldwide. B. bronchiseptica is involved in diverse respiratory infections in a wide range of mammals. SUMMARY Bordetella pertussis and Bordetella bronchiseptica belong to the genus Bordetella, which comprises 14 other species. B. pertussis is responsible for whooping cough in humans, a severe infection in children and less severe or chronic in adults. These infections are restricted to humans and currently increasing worldwide. B. bronchiseptica is involved in diverse respiratory infections in a wide range of mammals. For instance, the canine infectious respiratory disease complex (CIRDC), characterized by a chronic cough in dogs. At the same time, it is increasingly implicated in human infections, while remaining an important pathogen in the veterinary field. Both Bordetella can evade and modulate host immune responses to support their persistence, although it is more pronounced in B. bronchiseptica infection. The protective immune responses elicited by both pathogens are comparable, while there are important characteristics in the mechanisms that differ. However, B. pertussis pathogenesis is more difficult to decipher in animal models than those of B. bronchiseptica because of its restriction to humans. Nevertheless, the licensed vaccines for each Bordetella are different in terms of formulation, route of administration and immune responses induced, with no known cross-reaction between them. Moreover, the target of the mucosal tissues and the induction of long-lasting cellular and humoral responses are required to control and eliminate Bordetella. In addition, the interaction between both veterinary and human fields are essential for the control of this genus, by preventing the infections in animals and the subsequent zoonotic transmission to humans.

[1]  J. Mertsola,et al.  Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection , 2023, Emerging microbes & infections.

[2]  J. V. van Dongen,et al.  Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge , 2023, The Journal of clinical investigation.

[3]  J. Chandar,et al.  Case report: Bordetella holmesii: A rare pathogen causing infective endocarditis associated glomerulonephritis , 2023, Frontiers in Pediatrics.

[4]  Christine J. Boinett,et al.  "Antigen Discovery for Next-Generation Pertussis Vaccines using Immunoproteomics and Transposon Directed Insertion Sequencing". , 2022, The Journal of infectious diseases.

[5]  R. Borrow,et al.  A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients. , 2022, Expert review of vaccines.

[6]  N. Nakajima,et al.  Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia , 2022, Journal of global antimicrobial resistance.

[7]  J. Schrenzel,et al.  Missed pertussis diagnosis during co-infection with Bordetella holmesii , 2022, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  M. Biagi,et al.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Co-Infection in a Stem Cell Transplant Patient , 2022, Antibiotics.

[9]  Yingze Tian,et al.  The Lung Microbiota Affects Pulmonary Inflammation and Oxidative Stress Induced by PM2.5 Exposure. , 2022, Environmental science & technology.

[10]  F. H. Damron,et al.  CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in mice. , 2022, Vaccine.

[11]  A. Webster,et al.  Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000–2015 , 2022, Open forum infectious diseases.

[12]  R. Viswanathan,et al.  Looking beyond Pertussis in Prolonged Cough Illness of Young Children , 2022, Vaccines.

[13]  I. Kuitunen.  Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae Findings in Children During COVID-19 Pandemic in Finland , 2022, SN Comprehensive Clinical Medicine.

[14]  K. Jolley,et al.  A comprehensive resource for Bordetella genomic epidemiology and biodiversity studies , 2022, Nature Communications.

[15]  J. Tommassen,et al.  Regulated Expression of lpxC Allows for Reduction of Endotoxicity in Bordetella pertussis , 2022, International journal of molecular sciences.

[16]  Adonis Imam,et al.  Bordetella bronchiseptica empyema in patient with chronic alcohol use disorder , 2022, Respiratory medicine case reports.

[17]  X. Cui,et al.  Safety and Efficacy of the Bordetella bronchiseptica Vaccine Combined with a Vegetable Oil Adjuvant and Multi-Omics Analysis of Its Potential Role in the Protective Response of Rabbits , 2022, Pharmaceutics.

[18]  B. Wilson,et al.  Two Bordetella bronchiseptica attenuated vaccine candidates confer protection against lethal challenge with B. Bronchiseptica and Pasteurella multocida toxin in mouse models. , 2022, Vaccine.

[19]  P. Šebo,et al.  The Fim and FhaB adhesins play a crucial role in nasal cavity infection and Bordetella pertussis transmission in a novel mouse catarrhal infection model , 2022, PLoS pathogens.

[20]  P. Kalfon,et al.  Bordetella hinzii Pneumonia in Patient with SARS-CoV-2 Infection , 2022, Emerging infectious diseases.

[21]  T. T. Núñez,et al.  Neumonía secundaria por Bordetella hinzii en paciente con infección por SARS-CoV-2 , 2022, Revista Española de Quimioterapia.

[22]  T. Tosco Núñez,et al.  [Secondary Bordetella hinzii pneumonia in a patient with SARS-CoV-2 infection]. , 2022, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[23]  D. Litt,et al.  Impact of the COVID-19 pandemic on Bordetella pertussis infections in England , 2022, BMC Public Health.

[24]  E. Harvill,et al.  Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical Bordetella spp. , 2022, mSphere.

[25]  Sayo Yamamoto,et al.  Pathogenicity of Bordetella bronchiseptica isolated from apparently healthy rabbits in guinea pig, rat, and mouse , 2022, The Journal of veterinary medical science.

[26]  F. H. Damron,et al.  Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice , 2022, Frontiers in Immunology.

[27]  S. Oka,et al.  The First Reported Case of Bordetella pertussis Bacteremia in a Patient With Human Immunodeficiency Virus Infection , 2022, Open forum infectious diseases.

[28]  J. Maynard,et al.  Antibodies binding diverse pertactin epitopes protect mice from Bordetella pertussis infection , 2022, The Journal of biological chemistry.

[29]  Juan Mora-Delgado,et al.  Bordetella bronchiseptica pneumonia in an immunocompetent pig farmer , 2022, IDCases.

[30]  Q. Wei,et al.  Outer Membrane Vesicles Coating Nano-Glycyrrhizic Acid Confers Protection Against Borderella bronchiseptica Through Th1/Th2/Th17 Responses , 2022, International journal of nanomedicine.

[31]  Dena R Shibib,et al.  Bordetella bronchiseptica infections in patients with HIV/AIDS , 2021, Medicine.

[32]  L. Balboa,et al.  Human macrophage polarization shapes B. pertussis intracellular persistence , 2021, Journal of leukocyte biology.

[33]  S. R. Bennett,et al.  1045. Safety of the Synthetic Saponin Adjuvant TQL1055: Preliminary Results from a First-in-humans Trial , 2021, Open Forum Infectious Diseases.

[34]  C. Locht,et al.  Intranasal inoculation with Bordetella pertussis confers protection without inducing classical whooping cough in baboons , 2021, Current research in microbial sciences.

[35]  T. Hayakawa,et al.  Clinical evaluation of a new rapid immunochromatographic test for detection of Bordetella pertussis antigen , 2021, Scientific Reports.

[36]  P. Buchy,et al.  COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control , 2021, International Journal of Infectious Diseases.

[37]  C. Locht,et al.  The History of Pertussis Toxin , 2021, Toxins.

[38]  G. Sivasubramanian,et al.  Bordetella hinzii Pneumonia and Bacteremia in a Patient with SARS-CoV-2 Infection , 2021, Emerging infectious diseases.

[39]  Timothy D McHugh,et al.  Antimicrobial resistance profiles of bacteria associated with lower respiratory tract infections in cats and dogs in England. , 2021, The Veterinary record.

[40]  B. Linz,et al.  Pertactin contributes to shedding and transmission of Bordetella bronchiseptica , 2021, PLoS pathogens.

[41]  T. Hornung,et al.  Detection and Characterization of Clinical Bordetella trematum Isolates from Chronic Wounds , 2021, Pathogens.

[42]  B. Fougère,et al.  Erysipelas of the right arm due to Bordetella trematum: a case report , 2021, Journal of Medical Case Reports.

[43]  Haijian Zhou,et al.  Human Pneumonia Caused by Bordetella hinzii: First Case in Asia and Literature Review , 2021, Annals of laboratory medicine.

[44]  W. Liang,et al.  Isolation, Antimicrobial Resistance Phenotypes, and Virulence Genes of Bordetella bronchiseptica From Pigs in China, 2018–2020 , 2021, Frontiers in Veterinary Science.

[45]  E. Harvill,et al.  Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis , 2021, Emerging infectious diseases.

[46]  Theodoros Ladopoulos,et al.  A Case of Bordetella bronchiseptica Bacteremia in a Patient With COVID-19: Brief Report , 2021, Cureus.

[47]  C. Siegrist,et al.  Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease , 2021, Digestion.

[48]  N. Hens,et al.  Pertussis immunization during pregnancy: assessment of the role of maternal antibodies on immune responses in term and preterm born infants. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  E. Hewlett,et al.  Four single-basepair mutations in the ptx promoter of Bordetella bronchiseptica are sufficient to activate the expression of pertussis toxin , 2021, Scientific Reports.

[50]  C. Righolt,et al.  Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis. , 2021, Vaccine.

[51]  Jhasketan Badhai,et al.  Genomic plasticity and antibody response of Bordetella bronchiseptica strain HT200, a natural variant from a thermal spring. , 2021, FEMS microbiology letters.

[52]  C. Chiu,et al.  Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative , 2021, The Lancet regional health. Western Pacific.

[53]  Hidefumi Nakamura,et al.  Live attenuated vaccines under immunosuppressive agents or biological agents: survey and clinical data from Japan , 2021, European Journal of Pediatrics.

[54]  E. Bishburg,et al.  Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella bronchiseptica Pneumonia in a Renal Transplant Patient , 2021, Cureus.

[55]  T. Waterhouse,et al.  Frequency of respiratory pathogens and SARS‐CoV‐2 in canine and feline samples submitted for respiratory testing in early 2020 , 2021, The Journal of small animal practice.

[56]  Itai Sharon,et al.  Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization , 2021, Nature Communications.

[57]  J. Moore,et al.  Does Bordetella pertussis vaccine offer any cross‐protection against Bordetella bronchiseptica? Implications for pet owners with cystic fibrosis , 2021, Journal of clinical pharmacy and therapeutics.

[58]  T. Walles,et al.  Activity of Tracheal Cytotoxin of Bordetella pertussis in a Human Tracheobronchial 3D Tissue Model , 2021, Frontiers in Cellular and Infection Microbiology.

[59]  R. Mariman,et al.  Naturally circulating pertactin-deficient Bordetella pertussis strains induce distinct gene expression and inflammatory signatures in human dendritic cells , 2021, Emerging microbes & infections.

[60]  Philip S. Livingston,et al.  1238. The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21 , 2020 .

[61]  S. Madhi,et al.  Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa , 2020, Human vaccines & immunotherapeutics.

[62]  C. Radcliffe,et al.  Bordetella bronchiseptica: a rare cause of meningitis , 2020, BMC Infectious Diseases.

[63]  S. Shadomy,et al.  Role of Oral Rabies Vaccines in the Elimination of Dog-Mediated Human Rabies Deaths , 2020, Emerging infectious diseases.

[64]  K. Mills,et al.  Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract , 2020, Vaccines.

[65]  Y. Chiang,et al.  Thirteen-month duration of immunity of an oral canine vaccine against challenge with Bordetella bronchiseptica , 2020, Veterinary record open.

[66]  G. Blanchard-Rohner,et al.  Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[67]  T. Niedziela,et al.  Bordetella holmesii Lipopolysaccharide Hide and Seek Game with Pertussis: Structural Analysis of the O-Specific Polysaccharide and the Core Oligosaccharide of the Type Strain ATCC 51541 , 2020, International journal of molecular sciences.

[68]  E. Lesne,et al.  Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains , 2020, Frontiers in Microbiology.

[69]  E. Roels,et al.  Clinical response to 2 protocols of aerosolized gentamicin in 46 dogs with Bordetella bronchiseptica infection (2012‐2018) , 2020, Journal of veterinary internal medicine.

[70]  Derek J. Wilson,et al.  Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity , 2020, Communications Biology.

[71]  Derek J. Wilson,et al.  Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity , 2020, Communications Biology.

[72]  D. Levy-bruhl,et al.  Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013. , 2020, Medecine et maladies infectieuses.

[73]  M. A. Ballesteros,et al.  Acceso a pruebas complementarias para el diagnóstico de enfermedades infecciosas en las consultas de pediatría de atención primaria , 2020 .

[74]  E. Muñoz Hiraldo,et al.  [Access to complementary tests for the diagnosis of infectious diseases in primary care paediatric clinics]. , 2020, Anales de pediatria.

[75]  P. Šebo,et al.  Cytotoxicity of the effector protein BteA was attenuated in Bordetella pertussis by insertion of an alanine residue , 2020, bioRxiv.

[76]  B. Taminiau,et al.  Analysis of the lung microbiota in dogs with Bordetella bronchiseptica infection and correlation with culture and quantitative polymerase chain reaction , 2020, Veterinary Research.

[77]  E. Thiry,et al.  Aetiology of Canine Infectious Respiratory Disease Complex and Prevalence of its Pathogens in Europe , 2020, Journal of Comparative Pathology.

[78]  Y. Maeda,et al.  Bordetella Dermonecrotic Toxin Is a Neurotropic Virulence Factor That Uses CaV3.1 as the Cell Surface Receptor , 2020, mBio.

[79]  E. Garbe,et al.  Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review , 2020, BMC Infectious Diseases.

[80]  Yangang Xing,et al.  The impact of lung microbiota dysbiosis on inflammation , 2020, Immunology.

[81]  C. Locht,et al.  Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. , 2020, The Journal of clinical investigation.

[82]  C. Stanecki,et al.  Bordetella bronchiseptica Pneumonia in an Adolescent: Case Report and Review of the Pediatric Literature , 2019, Clinical pediatrics.

[83]  D. Kyle,et al.  Conservation of Ancient Genetic Pathways for Intracellular Persistence Among Animal Pathogenic Bordetellae , 2019, Front. Microbiol..

[84]  C. Bryant,et al.  Enhancement of immune response against Bordetella spp. by disrupting immunomodulation , 2019, Scientific Reports.

[85]  W. Liang,et al.  A Marker-Free Bordetella bronchiseptica aroA/bscN Double Deleted Mutant Confers Protection against Lethal Challenge , 2019, Vaccines.

[86]  F. H. Damron,et al.  Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis , 2019, npj Vaccines.

[87]  Kelsey A. Gregg,et al.  Pertussis Toxin: A Key Component in Pertussis Vaccines? , 2019, Toxins.

[88]  B. Laupeze,et al.  Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood. , 2019, Vaccine.

[89]  C. Ryu,et al.  Bacterial persistence: Fundamentals and clinical importance , 2019, Journal of Microbiology.

[90]  T. Uehara,et al.  A case of cervical subcutaneous abscess due to Bordetella hinzii. , 2019, Diagnostic microbiology and infectious disease.

[91]  K. Corps,et al.  Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant , 2019, Infection and Immunity.

[92]  W. Lubitz,et al.  Subcutaneous Immunization of Dogs With Bordetella bronchiseptica Bacterial Ghost Vaccine , 2019, Front. Immunol..

[93]  E. Hewlett,et al.  Bordetella pertussis Can Be Motile and Express Flagellum-Like Structures , 2019, mBio.

[94]  K. Mills,et al.  A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains , 2019, Front. Cell. Infect. Microbiol..

[95]  R. Berghaus,et al.  Canine infectious respiratory disease: New insights into the etiology and epidemiology of associated pathogens , 2019, PloS one.

[96]  Tetsuya Hayashi,et al.  BspR/BtrA, an Anti-σ Factor, Regulates the Ability of Bordetella bronchiseptica To Cause Cough in Rats , 2019, mSphere.

[97]  W. Ouyang,et al.  IL‐10 Family Cytokines IL‐10 and IL‐22: from Basic Science to Clinical Translation , 2019, Immunity.

[98]  M. Caroff,et al.  A comparative study of the complete lipopolysaccharide structures and biosynthesis loci of Bordetella avium, B. hinzii, and B. trematum. , 2019, Biochimie.

[99]  J. Mertsola,et al.  Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[100]  M. Haritani,et al.  An Outbreak of Fatal Bordetella bronchiseptica Bronchopneumonia in Puppies , 2019, Journal of Comparative Pathology.

[101]  C. Locht,et al.  The Role of Mucosal Immunity in Pertussis , 2019, Front. Immunol..

[102]  K. Mills,et al.  Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis , 2019, Emerging microbes & infections.

[103]  O. Levy,et al.  Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. , 2019, Vaccine.

[104]  D. Hozbor,et al.  Outer-Membrane-Vesicle–Associated O Antigen, a Crucial Component for Protecting Against Bordetella parapertussis Infection , 2018, Front. Immunol..

[105]  R. Geffers,et al.  Respiratory Bordetella bronchiseptica Carriage is Associated with Broad Phenotypic Alterations of Peripheral CD4+CD25+ T Cells and Differentially Affects Immune Responses to Secondary Non-Infectious and Infectious Stimuli in Mice , 2018, International journal of molecular sciences.

[106]  K. Mills,et al.  Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells , 2018, Mucosal Immunology.

[107]  Y. Chiang,et al.  Comparative onset of immunity of oral and intranasal vaccines against challenge with Bordetella bronchiseptica , 2018, Veterinary Record Open.

[108]  Jianhong Wu,et al.  Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study , 2018, PloS one.

[109]  K. Beavis,et al.  Misdiagnosis of Bordetella bronchiseptica Respiratory Infection as Bordetella pertussis by Multiplex Molecular Assay. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[110]  Aldert L. Zomer,et al.  Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines , 2018, Microbial genomics.

[111]  A. Gruber,et al.  Bordetella pseudohinzii targets cilia and impairs tracheal cilia-driven transport in naturally acquired infection in mice , 2018, Scientific Reports.

[112]  V. Sintchenko,et al.  Detection and incidence of Bordetella holmesii in respiratory specimens from patients with pertussis-like symptoms in New South Wales, Australia. , 2018, Pathology.

[113]  E. Roels,et al.  Detection of specific bacterial agents by quantitative PCR assays in the bronchoalveolar lavage fluid of dogs with eosinophilic bronchopneumopathy vs. dogs with chronic bronchitis and healthy dogs. , 2018, Veterinary journal.

[114]  I. Linhartova,et al.  Bordetella pertussis Adenylate Cyclase Toxin Disrupts Functional Integrity of Bronchial Epithelial Layers , 2017, Infection and Immunity.

[115]  D. Hozbor,et al.  Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen , 2017, Applied and Environmental Microbiology.

[116]  S. Copeland.  The Infant Microbiome , 2017, Clinical Lactation.

[117]  P. Šebo,et al.  Invasion of Dendritic Cells, Macrophages and Neutrophils by the Bordetella Adenylate Cyclase Toxin: A Subversive Move to Fool Host Immunity , 2017, Toxins.

[118]  R. A. van den Berg,et al.  Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity , 2017 .

[119]  N. Guiso.  Bordetella Adenylate Cyclase-Hemolysin Toxins , 2017, Toxins.

[120]  D. Hozbor.  Outer membrane vesicles: an attractive candidate for pertussis vaccines , 2017, Expert review of vaccines.

[121]  Timothy A. Whitehead,et al.  Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin. , 2017, Biochemistry.

[122]  A. Casabuono,et al.  Modifications of Bordetella bronchiseptica core lipopolysaccharide influence immune response without affecting protective activity. , 2017, Bioorganic & medicinal chemistry letters.

[123]  B. Linz,et al.  Environmental Origin of the Genus Bordetella , 2017, Front. Microbiol..

[124]  J. Parkhill,et al.  Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species , 2016, BMC Genomics.

[125]  M. Bankowski,et al.  Bordetella trematum sepsis with shock in a diabetic patient with rapidly developing soft tissue infection. , 2016, Diagnostic microbiology and infectious disease.

[126]  M. E. Rodriguez,et al.  Bordetella pertussis modulates human macrophage defense gene expression. , 2016, Pathogens and disease.

[127]  F. Shahcheraghi,et al.  Study on Toxicity Reduction and Potency Induction in Whole-cell Pertussis Vaccine by Developing a New Optimal Inactivation Condition Processed on Bordetella pertussis , 2016, Jundishapur journal of microbiology.

[128]  J. Ellis,et al.  Comparative efficacy of intranasal and oral vaccines against Bordetella bronchiseptica in dogs. , 2016, Veterinary journal.

[129]  P. Dubey,et al.  Bordetella biofilms: a lifestyle leading to persistent infections. , 2016, Pathogens and disease.

[130]  J. Sugiyama,et al.  Novel environmental species isolated from the plaster wall surface of mural paintings in the Takamatsuzuka tumulus: Bordetella muralis sp. nov., Bordetella tumulicola sp. nov. and Bordetella tumbae sp. nov. , 2015, International journal of systematic and evolutionary microbiology.

[131]  L. Paitoonpong,et al.  Adult pertussis is unrecognized public health problem in Thailand , 2015, BMC Infectious Diseases.

[132]  F. Mégraud,et al.  Opportunistic Pulmonary Bordetella hinzii Infection after Avian Exposure , 2015, Emerging infectious diseases.

[133]  T. Nicholson,et al.  Bordetella pertussis transmission. , 2015, Pathogens and disease.

[134]  Jayne Wright,et al.  A Review of the Comparative Anatomy, Histology, Physiology and Pathology of the Nasal Cavity of Rats, Mice, Dogs and Non-human Primates. Relevance to Inhalation Toxicology and Human Health Risk Assessment. , 2015, Journal of comparative pathology.

[135]  N. Carbonetti.  Contribution of pertussis toxin to the pathogenesis of pertussis disease. , 2015, Pathogens and disease.

[136]  P. Cotter,et al.  Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential. , 2015, Pathogens and disease.

[137]  R. Zhu,et al.  Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin. , 2015, International immunopharmacology.

[138]  P. Vandamme,et al.  Bordetella bronchialis sp. nov., Bordetella flabilis sp. nov. and Bordetella sputigena sp. nov., isolated from human respiratory specimens, and reclassification of Achromobacter sediminum Zhang et al. 2014 as Verticia sediminum gen. nov., comb. nov. , 2015, International journal of systematic and evolutionary microbiology.

[139]  P. Lambert,et al.  Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept. , 2015, Vaccine.

[140]  P. Cotter,et al.  Cooperative Roles for Fimbria and Filamentous Hemagglutinin in Bordetella Adherence and Immune Modulation , 2015, mBio.

[141]  P. Minor.  Live attenuated vaccines: Historical successes and current challenges. , 2015, Virology.

[142]  C. Rodriguez,et al.  Microbiological and clinical aspects of respiratory infections associated with Bordetella bronchiseptica. , 2015, Diagnostic microbiology and infectious disease.

[143]  J. Ellis.  How well do vaccines for Bordetella bronchiseptica work in dogs? A critical review of the literature 1977-2014. , 2015, Veterinary journal.

[144]  C. L. Ventola.  The antibiotic resistance crisis: part 1: causes and threats. , 2015, P & T : a peer-reviewed journal for formulary management.

[145]  S. Schubert,et al.  Bordetella trematum in chronic ulcers: report on two cases and review of the literature , 2015, Infection.

[146]  G. Dore,et al.  Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. , 2014, Vaccine.

[147]  T. Merkel,et al.  The baboon model of pertussis: effective use and lessons for pertussis vaccines , 2014, Expert review of vaccines.

[148]  A. Gorringe,et al.  Bordetella pertussis fimbriae (Fim): relevance for vaccines , 2014, Expert review of vaccines.

[149]  J. Mašín,et al.  Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines , 2014, Expert review of vaccines.

[150]  J. Ellis,et al.  Antibody responses to Bordetella bronchiseptica in vaccinated and infected dogs. , 2014, The Canadian veterinary journal = La revue veterinaire canadienne.

[151]  J. Schrenzel,et al.  Bordetella holmesii: an under-recognised Bordetella species. , 2014, The Lancet. Infectious diseases.

[152]  K. Hartmann,et al.  Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections , 2014, The Veterinary Journal.

[153]  Jeff F. Miller,et al.  Bordetella pertussis pathogenesis: current and future challenges , 2014, Nature Reviews Microbiology.

[154]  P. François,et al.  Diagnosis of Whooping Cough in Switzerland: Differentiating Bordetella pertussis from Bordetella holmesii by Polymerase Chain Reaction , 2014, PloS one.

[155]  T. Nicholson,et al.  The Bordetella bronchiseptica Type III Secretion System Is Required for Persistence and Disease Severity but Not Transmission in Swine , 2013, Infection and Immunity.

[156]  T. Merkel,et al.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model , 2013, Proceedings of the National Academy of Sciences.

[157]  Daniel A. Salmon,et al.  Nonmedical Vaccine Exemptions and Pertussis in California, 2010 , 2013, Pediatrics.

[158]  J. Clemente,et al.  Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice , 2013, Science.

[159]  S. Conlan,et al.  Adaptability and Persistence of the Emerging Pathogen Bordetella petrii , 2013, PloS one.

[160]  Hugues Bedouelle,et al.  In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. , 2013, Microbes and infection.

[161]  K. Krogfelt,et al.  Evaluation of PCR methods for the diagnosis of pertussis by the European surveillance network for vaccine-preventable diseases (EUVAC.NET) , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[162]  K. Mills,et al.  Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine , 2013, PLoS pathogens.

[163]  D. Raoult,et al.  Bordetella hinzii in Rodents, Southeast Asia , 2013, Emerging infectious diseases.

[164]  K. Spicer,et al.  Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[165]  F. Jamieson,et al.  Bordetella holmesii, an Emerging Cause of Septic Arthritis , 2013, Journal of Clinical Microbiology.

[166]  D. S. Horton,et al.  An improved whole cell pertussis vaccine with reduced content of endotoxin , 2013, Human vaccines & immunotherapeutics.

[167]  T. Merkel,et al.  Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates , 2012, Mucosal Immunology.

[168]  L. Weyrich,et al.  Lack of Cross-protection against Bordetella holmesii after Pertussis Vaccination , 2012, Emerging infectious diseases.

[169]  E. Harvill,et al.  Bordetella parapertussis Survives the Innate Interaction with Human Neutrophils by Impairing Bactericidal Trafficking inside the Cell through a Lipid Raft-Dependent Mechanism Mediated by the Lipopolysaccharide O Antigen , 2012, Infection and Immunity.

[170]  L. Martínez-Martínez,et al.  Recurrent respiratory infection caused by Bordetella bronchiseptica in an immunocompetent infant. , 2012, The Pediatric infectious disease journal.

[171]  C. Locht,et al.  Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. , 2012, Vaccine.

[172]  H. Ismail,et al.  Spontaneous bacterial peritonitis and pneumonia caused by Bordetella bronchiseptica. , 2012, Journal of infection in developing countries.

[173]  K. Taniguchi,et al.  Transmission of Bordetella holmesii during Pertussis Outbreak, Japan , 2012, Emerging infectious diseases.

[174]  K. Mills,et al.  Immunity to the respiratory pathogen Bordetella pertussis , 2012, Mucosal Immunology.

[175]  H. Smaoui,et al.  The diagnosis of pertussis: which method to choose? , 2012, Critical reviews in microbiology.

[176]  Erik L. Hewlett,et al.  Contribution of Bordetella Filamentous Hemagglutinin and Adenylate Cyclase Toxin to Suppression and Evasion of Interleukin-17-Mediated Inflammation , 2012, Infection and Immunity.

[177]  J. Keane,et al.  The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis. , 2012, FEMS immunology and medical microbiology.

[178]  J. Cherry,et al.  Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[179]  M. Tondella,et al.  Novel Multitarget Real-Time PCR Assay for Rapid Detection of Bordetella Species in Clinical Specimens , 2011, Journal of Clinical Microbiology.

[180]  Huanchun Chen,et al.  The occurrence of Bordetella bronchiseptica in pigs with clinical respiratory disease. , 2011, Veterinary journal.

[181]  H. Weiner,et al.  Oral tolerance , 2011, Immunological reviews.

[182]  S. Guillot,et al.  Bordetella petrii Infection with Long-lasting Persistence in Human , 2011, Emerging infectious diseases.

[183]  F. Mooi,et al.  Studies on Prn Variation in the Mouse Model and Comparison with Epidemiological Data , 2011, PloS one.

[184]  A. Abe,et al.  Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis , 2011, PloS one.

[185]  D. Maskell,et al.  Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine , 2011, Proceedings of the National Academy of Sciences.

[186]  A. van der Zee,et al.  A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three Insertion Sequence elements , 2011, BMC Research Notes.

[187]  R. Deora,et al.  The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesin , 2010, Molecular microbiology.

[188]  J. Tschopp,et al.  Inflammasome Activation by Adenylate Cyclase Toxin Directs Th17 Responses and Protection against Bordetella pertussis , 2010, The Journal of Immunology.

[189]  T. Nicholson,et al.  Evaluation of Specificity of BP3385 for Bordetella pertussis Detection , 2010, Journal of Clinical Microbiology.

[190]  C. Tato,et al.  Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.

[191]  D. Granoff.  Review of meningococcal group B vaccines. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[192]  E. Harvill,et al.  Intracellular Trafficking of Bordetella pertussis in Human Macrophages , 2010, Infection and Immunity.

[193]  C. Locht,et al.  Monocyte-Derived Interleukin-10 Depresses the Bordetella pertussis- Specific Gamma Interferon Response in Vaccinated Infants , 2009, Clinical and Vaccine Immunology.

[194]  H. Hallander,et al.  Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti‐Fim2/3 antibodies after vaccination and infection , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[195]  C. Locht,et al.  Genomic island excisions in Bordetella petrii , 2009, BMC Microbiology.

[196]  K. Register,et al.  Strain-Specific Virulence of Bordetella hinzii in Poultry , 2009, Avian diseases.

[197]  D. Relman,et al.  Natural‐host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C‐terminal domain, but not the RGD motif, during infection , 2009, Molecular microbiology.

[198]  T. Nicholson,et al.  Contribution of Bordetella bronchiseptica Filamentous Hemagglutinin and Pertactin to Respiratory Disease in Swine , 2009, Infection and Immunity.

[199]  B. Cookson,et al.  Isolation of Bordetella avium and Novel Bordetella Strain from Patients with Respiratory Disease , 2009, Emerging infectious diseases.

[200]  D. Relman,et al.  Modulation of the NF-κB Pathway by Bordetella pertussis Filamentous Hemagglutinin , 2008, PloS one.

[201]  O. Benada,et al.  Adenylate Cyclase Toxin Subverts Phagocyte Function by RhoA Inhibition and Unproductive Ruffling1 , 2008, The Journal of Immunology.

[202]  N. Carbonetti,et al.  Pertussis Toxin Inhibits Early Chemokine Production To Delay Neutrophil Recruitment in Response to Bordetella pertussis Respiratory Tract Infection in Mice , 2008, Infection and Immunity.

[203]  R. Fernandez,et al.  Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model. , 2008, Vaccine.

[204]  G. Fedele,et al.  Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis Differently Modulate Human Dendritic Cell Functions Resulting in Divergent Prevalence of Th17-Polarized Responses1 , 2008, The Journal of Immunology.

[205]  M. L. P. Perez Vidakovics,et al.  Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils. , 2008, Microbial pathogenesis.

[206]  J. Lipuma,et al.  Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[207]  B. Rath,et al.  Persistent Bordetella bronchiseptica pneumonia in an immunocompetent infant and genetic comparison of clinical isolates with kennel cough vaccine strains. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[208]  S. Pelton,et al.  Frequency of pertussis in children with prolongued cough , 2008, Scandinavian journal of infectious diseases.

[209]  O. Lyubomska,et al.  Oral vaccination: where we are? , 2007, Expert opinion on drug delivery.

[210]  N. Fry,et al.  The first UK isolate of 'Bordetella ansorpii' from an immunocompromised patient. , 2007, Journal of medical microbiology.

[211]  Eric T. Harvill,et al.  Comparative Role of Immunoglobulin A in Protective Immunity against the Bordetellae , 2007, Infection and Immunity.

[212]  R. Deora,et al.  The Bordetella Bps Polysaccharide Is Critical for Biofilm Development in the Mouse Respiratory Tract , 2007, Journal of bacteriology.

[213]  E. Coccia,et al.  Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response. , 2007, Microbes and infection.

[214]  D. Wolfe,et al.  Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. , 2007, Microbes and infection.

[215]  J. Poolman,et al.  Acellular pertussis vaccines and the role of pertactin and fimbriae , 2007, Expert review of vaccines.

[216]  G. Douce,et al.  Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice. , 2007, Vaccine.

[217]  Jason A. Skinner,et al.  Bordetella bronchiseptica Modulates Macrophage Phenotype Leading to the Inhibition of CD4+ T Cell Proliferation and the Initiation of a Th17 Immune Response1 , 2006, The Journal of Immunology.

[218]  J. Mertsola,et al.  Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. , 2006, Journal of medical microbiology.

[219]  D. Bernstein,et al.  Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[220]  B. Christman,et al.  Hospital-Acquired Bordetella bronchiseptica Infection following Hematopoietic Stem Cell Transplantation , 2006, Journal of Clinical Microbiology.

[221]  D. Relman,et al.  Species- and Strain-Specific Control of a Complex, Flexible Regulon by Bordetella BvgAS , 2006, Journal of bacteriology.

[222]  Eric T. Harvill,et al.  The Bordetella bronchiseptica Type III Secretion System Inhibits Gamma Interferon Production That Is Required for Efficient Antibody-Mediated Bacterial Clearance , 2006, Infection and Immunity.

[223]  Paul B. Mann,et al.  Comparative Toll-Like Receptor 4-Mediated Innate Host Defense to Bordetella Infection , 2005, Infection and Immunity.

[224]  Paul B. Mann,et al.  The Complex Mechanism of Antibody-Mediated Clearance of Bordetella from the Lungs Requires TLR41 , 2005, The Journal of Immunology.

[225]  Jason A. Skinner,et al.  Bordetella Type III Secretion Modulates Dendritic Cell Migration Resulting in Immunosuppression and Bacterial Persistence1 , 2005, The Journal of Immunology.

[226]  P. Nordmann,et al.  Chromosome-Borne Class A BOR-1 β-Lactamase of Bordetella bronchiseptica and Bordetella parapertussis , 2005, Antimicrobial Agents and Chemotherapy.

[227]  S. Boitano,et al.  Bordetella bronchiseptica Adherence to Cilia Is Mediated by Multiple Adhesin Factors and Blocked by Surfactant Protein A , 2005, Infection and Immunity.

[228]  Aaron M Wendelboe,et al.  Duration of Immunity Against Pertussis After Natural Infection or Vaccination , 2005, The Pediatric infectious disease journal.

[229]  K. Ko,et al.  New Species of Bordetella, Bordetella ansorpii sp. nov., Isolated from the Purulent Exudate of an Epidermal Cyst , 2005, Journal of Clinical Microbiology.

[230]  N. Carbonetti,et al.  Pertussis Toxin and Adenylate Cyclase Toxin Provide a One-Two Punch for Establishment of Bordetella pertussis Infection of the Respiratory Tract , 2005, Infection and Immunity.

[231]  Evelinda Trindade,et al.  Epidemiology of pertussis. , 2005, The Pediatric infectious disease journal.

[232]  L. Horspool,et al.  Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours , 2005, Veterinary Record.

[233]  Seema Mattoo,et al.  Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies , 2005, Clinical Microbiology Reviews.

[234]  F. McCormack,et al.  Interactions of Pulmonary Collectins with Bordetella bronchiseptica and Bordetella pertussis Lipopolysaccharide Elucidate the Structural Basis of Their Antimicrobial Activities , 2004, Infection and Immunity.

[235]  M. Corbel,et al.  Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. , 2004, Vaccine.

[236]  Yasuhiko Irie,et al.  The Bvg Virulence Control System Regulates Biofilm Formation in Bordetella bronchiseptica , 2004, Journal of bacteriology.

[237]  D. Maskell,et al.  Ciliostasis is a key early event during colonization of canine tracheal tissue by Bordetella bronchiseptica. , 2004, Microbiology.

[238]  K. Mills,et al.  Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen‐specific Th1 and enhancement of Th2, but not Tr1 cells , 2004, European journal of immunology.

[239]  Jason A. Skinner,et al.  Bordetella Type III Secretion and Adenylate Cyclase Toxin Synergize to Drive Dendritic Cells into a Semimature State1 , 2004, The Journal of Immunology.

[240]  Jeff F. Miller,et al.  Regulation of type III secretion in Bordetella , 2004, Molecular microbiology.

[241]  Paul B. Mann,et al.  Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. , 2004, The Journal of infectious diseases.

[242]  N. Carbonetti,et al.  Pertussis Toxin Plays an Early Role in Respiratory Tract Colonization by Bordetella pertussis , 2003, Infection and Immunity.

[243]  K. Mills,et al.  Toll-Like Receptor 4-Mediated Innate IL-10 Activates Antigen-Specific Regulatory T Cells and Confers Resistance to Bordetella pertussis by Inhibiting Inflammatory Pathology 1 , 2003, The Journal of Immunology.

[244]  B. Barrell,et al.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica , 2003, Nature Genetics.

[245]  J. Brownlie,et al.  Respiratory Disease in Kennelled Dogs: Serological Responses to Bordetella bronchiseptica Lipopolysaccharide Do Not Correlate with Bacterial Isolation or Clinical Respiratory Symptoms , 2003, Clinical Diagnostic Laboratory Immunology.

[246]  Paul B. Mann,et al.  Role of Antibodies in Immunity to Bordetella Infections , 2003, Infection and Immunity.

[247]  J. Poolman,et al.  Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection. , 2002, Vaccine.

[248]  P. Brennan,et al.  Infected Branchial Cleft Cyst Due toBordetella bronchiseptica in an Immunocompetent Patient , 2001, Journal of Clinical Microbiology.

[249]  F. Mooi,et al.  Immunoglobulin A-Mediated Protection against Bordetella pertussis Infection , 2001, Infection and Immunity.

[250]  U. Göbel,et al.  Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. , 2001, International journal of systematic and evolutionary microbiology.

[251]  C. Greene,et al.  Canine Vaccination , 2001, Veterinary Clinics of North America: Small Animal Practice.

[252]  F. Mooi,et al.  Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens. , 2000, Vaccine.

[253]  R. Gross,et al.  Phagosome Acidification Has Opposite Effects on Intracellular Survival of Bordetella pertussis andB. bronchiseptica , 2000, Infection and Immunity.

[254]  S. Brockmeier,et al.  Effect of temperature modulation and bvg mutation of Bordetella bronchiseptica on adhesion, intracellular survival and cytotoxicity for swine alveolar macrophages. , 2000, Veterinary microbiology.

[255]  Jeff F. Miller,et al.  Modulation of host immune responses, induction of apoptosis and inhibition of NF‐κB activation by the Bordetella type III secretion system , 2000, Molecular microbiology.

[256]  J. F. Chavez,et al.  Application of 16S rRNA Gene Sequencing To IdentifyBordetella hinzii as the Causative Agent of Fatal Septicemia , 2000, Journal of Clinical Microbiology.

[257]  N. Birkebaek,et al.  Bordetella pertussis and chronic cough in adults. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[258]  Eric T. Harvill,et al.  Pregenomic Comparative Analysis betweenBordetella bronchiseptica RB50 and Bordetella pertussis Tohama I in Murine Models of Respiratory Tract Infection , 1999, Infection and Immunity.

[259]  F. Fouque,et al.  Detection of Bordetella bronchiseptica by the polymerase chain reaction. , 1999, Research in microbiology.

[260]  W. Yih,et al.  Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. , 1999, Emerging infectious diseases.

[261]  F. Mooi,et al.  Role of Bordetella pertussis Virulence Factors in Adherence to Epithelial Cell Lines Derived from the Human Respiratory Tract , 1999, Infection and Immunity.

[262]  J. Gornbein,et al.  A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. , 1998, Vaccine.

[263]  H. Hallander,et al.  Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. , 1998, Vaccine.

[264]  L. Temple,et al.  Bordetella avium Virulence Measured In Vivo and In Vitro , 1998, Infection and Immunity.

[265]  S. Salmaso,et al.  Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. , 1998, The Journal of pediatrics.

[266]  K. Mills,et al.  A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection againstBordetella pertussis , 1998, Infection and Immunity.

[267]  K. Mills,et al.  Distinct T‐cell subtypes induced with whole cell and acellular pertussis vaccines in children , 1998, Immunology.

[268]  K. Mills,et al.  Atypical Disease after Bordetella pertussis Respiratory Infection of Mice with Targeted Disruptions of Interferon-γ Receptor or Immunoglobulin μ Chain Genes , 1997, The Journal of experimental medicine.

[269]  P. Mastrantonio,et al.  Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs , 1997, Journal of clinical microbiology.

[270]  A. la Sala,et al.  Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines , 1997, Infection and immunity.

[271]  K. Mills,et al.  Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. , 1997, The Journal of infectious diseases.

[272]  Jeff F. Miller,et al.  A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg‐regulated antigens , 1997, Molecular microbiology.

[273]  Jeff F. Miller,et al.  Central Role of the BvgS Receiver as a Phosphorylated Intermediate in a Complex Two-component Phosphorelay* , 1996, The Journal of Biological Chemistry.

[274]  Jeff F. Miller,et al.  Comparative analysis of the virulence control systems of Bordetella pertussis and Bordetella bronchiseptica , 1996, Molecular microbiology.

[275]  P. de Vos,et al.  Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Rüger and Tan 1983. , 1996, International journal of systematic bacteriology.

[276]  P. Vandamme,et al.  Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period , 1996, Journal of clinical microbiology.

[277]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[278]  B. McBride,et al.  Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection , 1996, Infection and immunity.

[279]  P. Gueirard,et al.  Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host , 1995, Journal of clinical microbiology.

[280]  K. Timmis,et al.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells , 1994, Infection and immunity.

[281]  W. Donachie,et al.  Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. , 1994, Microbiology.

[282]  Jeff F. Miller,et al.  Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system , 1993, Journal of bacteriology.

[283]  E. Akporiaye,et al.  Uptake and intracellular survival of Bordetella pertussis in human macrophages , 1992, Infection and immunity.

[284]  F. Mooi,et al.  Construction and analysis of Bordetella pertussis mutants defective in the production of fimbriae. , 1992, Microbial pathogenesis.

[285]  B. Woolfrey,et al.  Human infections associated with Bordetella bronchiseptica , 1991, Clinical Microbiology Reviews.

[286]  A. Wardlaw,et al.  Growth and survival of Bordetella bronchiseptica in natural waters and in buffered saline without added nutrients , 1991, Applied and environmental microbiology.

[287]  P. Novotný,et al.  Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets , 1990, Infection and immunity.

[288]  A. Gilles,et al.  Characterization of the calmodulin-binding and of the catalytic domains of Bordetella pertussis adenylate cyclase. , 1989, The Journal of biological chemistry.

[289]  A. Steven,et al.  Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis , 1988, Infection and immunity.

[290]  R. Gupta,et al.  Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine. , 1988, Vaccine.

[291]  R. Rappuoli,et al.  Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes , 1987, Journal of bacteriology.

[292]  S. Bernander,et al.  Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects , 1987, The Pediatric infectious disease journal.

[293]  C. Manclark,et al.  Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. , 1984, The Journal of infectious diseases.

[294]  D. Bemis,et al.  An improved system for studying the effect of Bordetella bronchiseptica on the ciliary activity of canine tracheal epithelial cells. , 1981, The Journal of infectious diseases.

[295]  I. McCandlish,et al.  Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine. , 1978, Research in veterinary science.

[296]  I. McCandlish,et al.  Vaccination against canine bordetellosis using an aluminum hydroxide adjuvant vaccine. , 1978, Research in veterinary science.

[297]  OUP accepted manuscript , 2021, Clinical Infectious Diseases.

[298]  H. D. de Melker,et al.  Asymptomatic infection and transmission of pertussis in households: a systematic review. , 2019, Clinical Infectious Diseases.

[299]  Pertussis Infection and Vaccines: Advances in Microbiology, Infectious Diseases and Public Health Volume 12 , 2019, Advances in Experimental Medicine and Biology.

[300]  Nuha Mobarki,et al.  Antibiotic Resistance Crisis , 2019, International Journal of Medicine in Developing Countries.

[301]  A. Evangelista,et al.  Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007–2014 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[302]  M. Pokorski.  Pathobiology of Pulmonary Disorders , 2017 .

[303]  K. Posfay-Barbe,et al.  Bordetella holmesii: Still Emerging and Elusive 20 Years On , 2016, Microbiology spectrum.

[304]  E. Wehmann,et al.  Heterogeneity of Bordetella bronchiseptica adenylate cyclase (cyaA) RTX domain , 2014, Archives of Microbiology.

[305]  L. Larson,et al.  A Comparative Study of Protective Immunity Provided by Oral, Intranasal and Parenteral Canine Bordetella bronchiseptica Vaccines , 2013 .

[306]  S. Guillot,et al.  Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[307]  V. Sintchenko,et al.  Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. , 2011, Molecular biology and evolution.

[308]  T. Hess,et al.  Evaluation of Efficacy of Oral Administration of Bordetella bronchiseptica Intranasal Vaccine When Used to Protect Puppies from Tracheobronchitis Due to B bronchiseptica Infection , 2011 .

[309]  D. Sweeney,et al.  Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs. , 2008, Veterinary therapeutics : research in applied veterinary medicine.

[310]  D. Sweeney,et al.  Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica. , 2007, Veterinary therapeutics : research in applied veterinary medicine.

[311]  J. Reing,et al.  Pneumonia caused by bordetella bronchiseptica in a patient with a thoracic trauma , 2005, Infection.

[312]  R. Rappuoli,et al.  The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins. , 2005, The Journal of infectious diseases.

[313]  D. Maskell,et al.  Multiple Roles for Bordetella Lipopolysaccharide Molecules during Respiratory Tract Infection , 2000 .

[314]  Jeff F. Miller,et al.  Role of Bordetella bronchiseptica Fimbriae in Tracheal Colonization and Development of a Humoral Immune Response , 2000 .

[315]  J. Storsaeter,et al.  Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance. , 1992, Vaccine.

[316]  C. Datz.  Bordetella Infections in Dogs and Cats : Treatment and Prevention , 2022 .